Stents for the Gastrointestinal Tract and Nutritional Implications
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Gastrointestinal Cancers a Multidisciplinary Approach to Screening, Diagnosis, and Treatment
Second Annual Update on Gastrointestinal Cancers A Multidisciplinary Approach to Screening, Diagnosis, and Treatment Friday, September 27, 2013 7:00am – 4:10pm COURSE DIRECTORS K.S. Clifford Chao, MD Michel Kahaleh, MD, AGAF, FACG, FASGE P. Ravi Kiran, MBBS, MS, FRCS, FACS Tyvin Rich, MD, FACR LOCATION Columbia University Medical Center Bard Hall New York City Register Online www.columbiasurgerycme.org Second Annual Update on Gastrointestinal Cancers A Multidisciplinary Approach to Screening, Diagnosis, and Treatment OVERVIEW EDUCATIONAL OBJECTIVES This course consists of lectures, case It is intended that this Continuing presentations, and Q&A panels with Medical Education (CME) activity will lead expert faculty. The course is broken into to improved patient care. At the conclusion five sessions, each covering gastrointestinal of this activity, participants should be able to: cancer in a specific area of the GI tract. 1. Identify new technologies and modalities Speakers in each session will cover research in the screening, surveillance, and diagnosis and the latest standards of care including of relevant gastrointestinal cancers. new innovations for screening, diagnosis, and treatment modalities including radiation 2. Offer patients non-invasive, interventional, therapy, chemotherapy, and surgery. This medical, and surgical approaches in the course will increase participant familiariza- treatment of gastrointestinal cancers. tion with current guidelines and recommen- 3. Identify emerging new chemotherapy, dations, and focus on the multidisciplinary targeted therapy, and radiation therapy team involved in the care of patients with options and approaches in the treatment gastrointestinal cancers. of gastrointestinal cancers. IDENTIFIED PRACTICE GAP/ 4. Apply their enhanced understanding of EDUCATIONAL NEEDS the benefits of the multidisciplinary approach to the screening, diagnosis, Gastrointestinal cancers include several treatment, and palliation of patients with malignancies, including those of the gastrointestinal cancers. -
Practice Patterns and Use of Endoscopic Retrograde
Practice patterns and use of endoscopic retrograde cholangiopancreatography in the management of recurrent acute pancreatitis Qiang Cai, Emory University Field Willingham, Emory University Steven Keilin, Emory University Vaishali Patel, Emory University Parit Mekaroonkamol, Emory University JB Reichstein, Duke University S Dacha, Emory University Journal Title: Clinical Endoscopy Volume: Volume 53, Number 1 Publisher: (publisher) | 2019-01-01, Pages 73-81 Type of Work: Article Publisher DOI: 10.5946/ce.2019.052 Permanent URL: https://pid.emory.edu/ark:/25593/vhjfb Final published version: http://dx.doi.org/10.5946/ce.2019.052 Accessed September 27, 2021 7:02 AM EDT ORIGINAL ARTICLE Clin Endosc 2020;53:73-81 https://doi.org/10.5946/ce.2019.052 Print ISSN 2234-2400 • On-line ISSN 2234-2443 Open Access Practice Patterns and Use of Endoscopic Retrograde Cholangiopancreatography in the Management of Recurrent Acute Pancreatitis Jonathan B. Reichstein1, Vaishali Patel2, Parit Mekaroonkamol2, Sunil Dacha2, Steven A. Keilin2, Qiang Cai2 and Field F. Willingham2 1Department of Medicine, Duke University, Durham, NC, 2Division of Digestive Disease, Department of Medicine, Emory University, Atlanta, GA, USA Background/Aims: There are conflicting opinions regarding the management of recurrent acute pancreatitis (RAP). While some physicians recommend endoscopic retrograde cholangiopancreatography (ERCP) in this setting, others consider it to be contraindicated in patients with RAP. The aim of this study was to assess the practice patterns and clinical features influencing the management of RAP in the US. Methods: An anonymous 35-question survey instrument was developed and refined through multiple iterations, and its use was approved by our Institutional Review Board. -
Interventional Innovations in Digestive Care to Receive the Negotiated Group Rate
The First Annual Peter D. Stevens Course on Interventional Innovations in Digestive Ca re Special Sessions: Hands-on Animal Tissue Labs, Live OR & Interventional Cases April 2 6–27, 2012 New York City Program Co-Directors: Michel Kahaleh, MD, AGAF, FACG, FASGE Robbyn Sockolow, MD, AGAF Marc Bessler, MD, FACS Jeffrey Milsom, MD, FACS, FACG www.gi-innovations.org Endorsed by This course is endorsed by the American Society for Endorsed by the Gastrointestinal Endoscopy AGA Institute Interventional Innov ations in Digestive Ca re n Overall Goals This two day course will inform participants of the latest innovations for the management of gastrointestinal diseases and disorders, and will offer a unique opportunity to learn more about the current trends in interventional endoscopic and surgical procedures. Internationally recognized faculty will address issues in current clinical practice, compli - cations and pitfalls of newer technologies, and the evolution of the field. Using a systems- based approach, the format will cover all major areas of digestive care and treatment options. Attendee participation and interaction will be emphasized and facilitated through Q & A sessions, live OR and interactive case presentations, hands-on animal tissue labs and meet the professor break-out sessions. n Learning Objectives • Understand endoscopic necrosectomy • Understand the use of ablation • Increase knowledge of the latest therapy for bile duct cancer innovations in minimally invasive • Learn the latest advances in techniques in bariatrics endoscopic -
Endoscopic Ultrasound
CLINICAL GASTROENTEROLOGY Series Editor George Y. Wu University of Connecticut Health Center, Farmington, CT, USA For further volumes: http://www.springer.com/series/7672 Endoscopic Ultrasound Edited by VANESSA M. SHA M I , MD Director of Endoscopic Ultrasound University of Virginia Health System Digestive Health Center, USA and MICHEL KAHALEH , MD Director of Pancreatico-Biliary Services University of Virginia Health System Digestive Health Center, USA Editors Vanessa M. Shami, MD Michel Kahaleh, MD Associate Professor of Medicine Associate Professor of Medicine Director of Endoscopic Ultrasound Director of Pancreatico-Biliary Services Digestive Health Center Digestive Health Center University of Virginia Health System University of Virginia Health System Charlottesville, VA, USA Charlottesville, USA [email protected] [email protected] ISBN 978-1-60327-479-1 e-ISBN 978-1-60327-480-7 DOI 10.1007/978-1-60327-480-7 Springer New York Dordrecht Heidelberg London Library of Congress Control Number: 2010930043 © Springer Science+Business Media, LLC 2010 All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Humana Press, c/o Springer Science+Business Media, LLC, 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks, and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. -
Use of Esophageal Stents After Anastomotic Leakage in Surgery for Gastric Adenocarcinoma Case Report and Review of the Literature
ISSN: 2574-1241 Volume 5- Issue 4: 2018 DOI: 10.26717/BJSTR.2018.06.001391 Fernando Mendoza-Moreno. Biomed J Sci & Tech Res Case Report Open Access Use of Esophageal Stents After Anastomotic Leakage in Surgery for Gastric Adenocarcinoma Case Report and Review of the Literature Mendoza-Moreno F*1, Díez-Gago MR2, Mínguez-García J1, Enjuto-Martínez DT1,Tallón-Iglesias B1, Solana-Maoño M1 and Argüello-de-Andrés JM1 1Department of General and Digestive Surgery,Sanitas La Moraleja Teaching Hospital, Spain 2Department of Emergency, Príncipe de Asturias Teaching Hospital, Spain Received: July 4, 2018; Published: July 12, 2018 *Corresponding author: Fernando Mendoza-Moreno, Department of General and Digestive Surgery, Sanitas La Moraleja Teaching Hospital, Madrid, Spain Abstract Introduction: Radical gastrectomy is the treatment of choice for the treatment of gastric cancer located in the upper third of stomach or in case of diffuse histology or cells in a signet ring. The worst complication after a radical gastrectomy is the leakage of the esophago-jejunal anastomosis, since it considerably increases the morbidity and mortality of the patient. Case Report: Wedescribe our experience after performing a radical gastrectomy for gastric adenocarcinoma in a patient who developed a leakage of the esophago-jejunal anastomosis in the postoperative period. Although he was reoperated, performing reinforcement of the anastomosis and making a feeding jejunostomy, the dehiscence progressed in the following days until it became almost complete. Then, we proceeded to place a digestive endoprosthesis through gastroscopy with good results, allowing the entire defect to heal and being able to be removed without incidents after 8 weeks. -
Long-Term Outcomes and Complications of Metallic Stents for Malignant Esophageal Stenoses
Kobe J. Med. Sci., Vol. 49, No. 6, pp. 133-142, 2003 Long-term Outcomes and Complications of Metallic Stents for Malignant Esophageal Stenoses RYOTA KAWASAKI1, AKIRA SANO2, and SHINICHI MATSUMOTO2 Department of Radiology, Kobe University Graduate School of Medicine, Kobe1, Department of Radiology, Tenri Hospital, Tenri, Nara2 Received 13 January 2004/ Accepted 6 February 2004 Key words: Esophagus; Malignant Stenoses; Ultraflex Stents; Outcomes; Complications Thirty patients with malignant esophageal stenosis underwent Ultraflex esophageal stent deployment and were followed up for a maximum of 29 months from June 1995 to August 2001 in Tenri Hospital. Twelve stents were in the upper esophagus, and nine each in the middle and lower esophagus. The procedures were successful and dysphagia scores improved from 2.9 to 0.7. Major complications such as esophagorespiratory fistula, hematemesis, or airway compression occurred in 9 patients, more often in the upper esophagus than in other parts of the esophagus, with no statistical difference. There was a significant difference in the onset of major complications between the upper and middle esophagus, as well as between the upper and middle-lower esophagus (p<0.05), but no difference in mean survival time between locations, or patients with or without major complications. These results demonstrate that esophageal stent deployment is effective for relieving dysphagia and associating malnutrition. But major complications may occur in the upper esophagus more often and earlier than in other parts. Metallic stents are effective in relieving those patients with malignant esophageal stenosis from their suffering from dysphagia and malnutrition. On the other hand, several serious complications after the stent deployment or during the long-term follow up have been described in the literature, which include massive bleeding, tracheal compression, esophagorespiratory fistula, and esophageal compression1-10). -
Tracheoesophageal Fistula(TEF), Tracheostomy, Nasogastric Tube, Esophageal Stent, Trichloroacetic Acid (TCA)
hf RACI PHAGEAL FISTULA: ON IN MANAGEMENT Surinder K. Singhal,* Ramandeep S.Virk, ** Arjun Dass,*** Biinaljit Singh Sandhu**** Key words: Tracheoesophageal fistula(TEF), Tracheostomy, Nasogastric tube, esophageal stent, trichloroacetic Acid (TCA). INTRODUCTION: & vomiting after taking food. The patient was a known diabetic and hypertensive on regular treatment. She had undergone a Tracheoesophageal fistula (TEF) is a communication between the medical termination of pregnancy and developed a faecal fistula. esophagus and trachea which can be congenital or acquired. She was operated for the fecal fistula and a colostomy was also About 80% of the acquired tracheoesophageal fistulae are done but on the second post operative day she had cardiac malignant and rest non-malignant' . arrest. She was intubated and revived. Later she underwent a Nonmalignant fistulae are usually due to trauma which can be tracheostomy and remained on ventilatory support for two iatrogenic, internal or external. latrogenic fistulae may occur weeks. She was gradually weaned off the ventilator and on 19` 1 following mechanical ventilation or as a complication of day of tracheostomy she was decanulated and discharged. tracheostomy. Internal trauma may be due to cuffed endotracheal She came back after a week with the complaints of violent cough, tube or nasogastric tubes or a combination of both. It may be regurgitation and vomiting after meals. Systemic examination external trauma from penetrating foreign bodies, open or closed was within normal limits. Colostomy bag was in situ. Local aero digestive tract injuries' .There are many risk factors examination revealed a tracheostomy scar. Oral cavity and associated with post intubation tracheoesophageal fistula like Oropharynx were unremarkable. -
Biodegradable Esophageal Stents for the Treatment of Refractory Benign Esophageal Strictures
INVITED REVIEW Annals of Gastroenterology (2020) 33, 1-8 Biodegradable esophageal stents for the treatment of refractory benign esophageal strictures Paraskevas Gkolfakisa, Peter D. Siersemab, Georgios Tziatziosc, Konstantinos Triantafyllouc, Ioannis S. Papanikolaouc Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium; Radboud University Medical Center, Nijmegen, The Netherlands; “Attikon” University General Hospital, Medical School, National and Kapodistrian University of Athens, Greece Abstract This review attempts to present the available evidence regarding the use of biodegradable stents in refractory benign esophageal strictures, especially highlighting their impact on clinical success and complications. A comprehensive literature search was conducted in PubMed, using the terms “biodegradable” and “benign”; evidence from cohort and comparative studies, as well as data from one pooled analysis and one meta-analysis are presented. In summary, the results from these studies indicate that the effectiveness of biodegradable stents ranges from more than one third to a quarter of cases, fairly similar to other types of stents used for the same indication. However, their implementation may reduce the need for re-intervention during follow up. Biodegradable stents also seem to reduce the need for additional types of endoscopic therapeutic modalities, mostly balloon or bougie dilations. Results from pooled data are consistent, showing moderate efficacy along with a higher complication rate. Nonetheless, the validity of these results is questionable, given the heterogeneity of the studies included. Finally, adverse events may occur at a higher rate but are most often minor. The lack of high-quality studies with sufficient patient numbers mandates further studies, preferably randomized, to elucidate the exact role of biodegradable stents in the treatment of refractory benign esophageal strictures. -
Redalyc.Esophageal Metalic Stent Migration. Case Report of A
Acta Gastroenterológica Latinoamericana ISSN: 0300-9033 [email protected] Sociedad Argentina de Gastroenterología Argentina Rubio Mainardi, María Soledad; Alcaraz, Álvaro; Patricia, Saleg; Romero, María Eugenia; Moser, Federico; Obeide, Lucio Ricardo Esophageal metalic stent migration. Case report of a dislodged stent retrieval Acta Gastroenterológica Latinoamericana, vol. 45, núm. 4, 2015, pp. 320-322 Sociedad Argentina de Gastroenterología Buenos Aires, Argentina Available in: http://www.redalyc.org/articulo.oa?id=199343433010 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative ♦CASO CLÍNICO Esophageal metalic stent migration. Case report of a dislodged stent retrieval María Soledad Rubio Mainardi, Álvaro Alcaraz, Saleg Patricia, María Eugenia Romero, Federico Moser, Lucio Ricardo Obeide Departamento de Cirugía General del Hospital Privado de Córdoba. Córdoba, Argentina. Acta Gastroenterol Latinoam 2015;45:320-322 Recibido: 29/03/2015 / Aprobado: 10/07/2015 / Publicado en www.actagastro.org el 30/12/2015 Summary ciente se recuperó sin complicaciones. Conclusión. Este caso Background. Metallic stent placing is the first choice in the ilustra que la técnica laparoscópica puede ser una forma opcio- treatment of malign or benign strictures of the esophagus. Stent nal para recuperar stents migrados en pacientes seleccionados. migration is a well-known complication of this procedure. We Palabras claves. Migración de stent, complicación de stent, report a case of stent migration in which surgical laparoscopic técnica laparoscópica, cáncer esofágico. intervention was used to retrieve it. Methods. -
Mega Stents: a New Option for Management of Leaks Following Laparoscopic Sleeve Gastrectomy… Endoscopy 2014; 46: E49–E50 E50 Cases and Techniques Library (CTL)
Cases and Techniques Library (CTL) E49 Postoperative leaks occur after laparo- scopic sleeve gastrectomy (LSG) in 1% – Mega stents: a new option for management of leaks 3% of cases [1]. Placement of covered me- following laparoscopic sleeve gastrectomy tallic stents is an effective treatment strat- egy [2,3], but in about 16.9% of cases stent migration occurs [4]. To avoid the compli- cation of stent migration, we have used a large stent (Niti-S Mega esophageal stent; Fig. 1 Contrast- Taewoong Medical, Gyeonggi-do, South enhanced computed tomography of the Korea) in two patients who developed abdomen of a 50-year- leaks following LSG. The first patient was old woman who devel- a 50-year-old woman with a body mass in- oped abdominal pain dex (BMI) of 35, who developed abdominal and vomiting 2 days pain and vomiting 2 days after LSG. Con- after laparoscopic trast-enhanced computed tomography sleeve gastrectomy, (CECT) of her abdomen revealed two showing perigastric collections with con- perigastric collections with contrast leak trast leak. (●" Fig.1). Endoscopy showed a fistulous opening at the gastroesophageal junction (●" Fig.2). A fully covered Mega esopha- geal stent (length 23cm; diameter: body 24mm, flanges 32mm) was placed under fluoroscopic guidance with the proximal end in the esophagus and the distal end in suprapapillary position in the descending duodenum using a fluoroscopic marker, thus covering the entire stomach sleeve (●" Fig.3). Repeat abdominal CECT re- vealed no collection at 8 weeks and the stent (●" Fig.4) was removed. The second patient was a 45-year-old woman (BMI 48.4) who developed ab- dominal pain, fever, and dyspnea on the 3rd postoperative day, requiring ventila- tory support. -
Development and Implementation of a New Nitinol Stent Design for Managing Benign Stenoses and Fistulas of the Digestive Tract
Original articles Development and Implementation of a New Nitinol Stent Design for Managing Benign Stenoses and Fistulas of the Digestive Tract Rodrigo Castaño, MD,1 Oscar Álvarez, MD,2 Jorge Lopera,3 Mario H. Ruiz, MD,4 Andrés Rojas, MD,5 Alejandra Álvarez,6 Luis Miguel Ruiz,6 David Restrepo.7 1 Gastrointestinal Surgery and Endoscopy. Abstract Chief of Postgraduate General Surgery (UPB), Gastrohepatology Group at the University of Background: Benign stenoses, digestive tract ruptures and fistulas are conditions that endanger life and Antioquia, Institute of Clinical Oncology of the are often treated surgically. Recently, the placement of partially or fully covered metal stents has emerged Americas in Medellin, Colombia. rcastanoll@ as a minimally invasive treatment option. This article looks at a new design for stents to determine its clinical hotmail.com 2 Gastroenterologist at Texas Valley Coastal Bend effectiveness. The new stent is a completely covered nitinol stent for treatment of gastrointestinal perforations Veterans Administration Hospital and Clinical Assistant and anastomotic leaks. This article places special emphasis on evaluating reactive hyperplasia. Professor at the University of Texas Health Science Methods: Fifteen had the new completely covered self-expanding nitinol stent placed for treatment of Center at San Antonio in San Antonio, Texas USA 3 Interventional Radiologist at the University of Texas benign esophageal perforations, anastomotic leaks, and stenoses following upper or lower gastrointestinal in the United States. surgery during 2012 and 2013. The stents are 20 mm in diameter in the middle and 28 mm in diameter at the 4 General Surgeon at the Hospital Pablo Tobón Uribe in proximal end. -
Adverse Events of Upper GI Endoscopy
GUIDELINE Adverse events of upper GI endoscopy This is one of a series of statements discussing the use of lications rely on self-reporting, and most reported data GI endoscopy in common clinical situations. The Stan- collected only from the immediate periprocedure period, dards of Practice Committee of the American Society for thus the rate of late adverse events and mortality may be Gastrointestinal Endoscopy (ASGE) prepared this text. underestimated.8,9 Major adverse events related to diag- In preparing this document, a search of the medical liter- nostic UGI endoscopy are rare and include cardiopulmo- ature was performed by using PubMed. Additional refer- nary adverse events, infection, perforation, and bleeding. ences were obtained from the bibliographies of the identi- Adverse events of ERCP and EUS are discussed in separate fied articles and from recommendations of expert ASGE documents.10,11 consultants. When few or no data exist from well-designed prospective trials, emphasis is given to results of large series and reports from recognized experts. This document is ADVERSE EVENTS ASSOCIATED WITH based on a critical review of the available data and expert DIAGNOSTIC UGI ENDOSCOPY consensus at the time that the document was drafted. Further controlled clinical studies may be needed to clar- Cardiopulmonary adverse events ify aspects of this document. This document may be re- Most UGI procedures in the United States and Europe vised as necessary to account for changes in technology, are performed with patients under sedation (moderate or 12 new data, or other aspects of clinical practice. deep). Cardiopulmonary adverse events related to seda- This document is intended to be an educational device tion and analgesia account for as much as 60% of UGI 1-4,7 to provide information that may assist endoscopists in endoscopy adverse events.